Notification of cessation of securities - TLX

Oct 4, 2026 at 9:27 PM UTC · Issued by Telix Pharmaceuticals Limited

Watch Telix Pharmaceuticals explain itTelix Pharm Ltd (TLPPF) Q2 2026 Earnings Call · Replay · Aug 20

Announcement Summary

Entity name
TELIX PHARMACEUTICALS LIMITED
Announcement Type
New announcement
Date of this announcement
Monday October 05, 2026
Details of +securities that have ceased
ASX +security	Number of +securities that	The +securities have	Date of
code Security description	have ceased	ceased due to	cessation
TLXAZ SHARE RIGHTS US	26,000	Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied	30/09/2026
TLXAP SHARE RIGHTS	76,000	Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied	30/09/2026
TLXAO SHARE APPRECIATION RIGHTS	221,000	Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied	30/09/2026
TLXAW PERFORMANCE SHARE APPRECIATION RIGHTS US 2025	257,663	Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied	30/09/2026

Refer to next page for full details of the announcement

Part 1 - Announcement Details

Name of +Entity
TELIX PHARMACEUTICALS LIMITED
We (the entity named above) provide the following information about our issued capital.
Registered Number Type
ACN
Registration Number
616620369
ASX issuer code
TLX
The announcement is
New announcement
Date of this announcement

5/10/2026

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

TLXAP : SHARE RIGHTS

Unquoted +equity securities that have ceased Number of securities that have ceased 76,000 Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation

30/9/2026

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation? ASX +Security Code and Description

TLXAZ : SHARE RIGHTS US

Unquoted +equity securities that have ceased Number of securities that have ceased 26,000 Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation

30/9/2026

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation? ASX +Security Code and Description

TLXAW : PERFORMANCE SHARE APPRECIATION RIGHTS US 2025

Unquoted +equity securities that have ceased Number of securities that have ceased 257,663 Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation

30/9/2026

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation? ASX +Security Code and Description

TLXAO : SHARE APPRECIATION RIGHTS

Unquoted +equity securities that have ceased Number of securities that have ceased 221,000 Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation

30/9/2026

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation?

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) Total number of ASX +security code and description +securities on issue
TLX : ORDINARY FULLY PAID 339,894,019
Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

Total number of

ASX +security code and description	+securities on issue
TLXAY : DEFERRED SHARE RIGHTS	66,140
TLXAX : DEFERRED SHARE RIGHTS EX-US	87,649
TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	15,000
TLXAZ : SHARE RIGHTS US	430,742
TLXAR : PERFORMANCE RIGHTS	9,965,235
TLXAP : SHARE RIGHTS	1,095,000
TLXAO : SHARE APPRECIATION RIGHTS	15,170,074
TLXAT : CONVERTIBLE NOTES	6,250
TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAU : DEFERRED SHARE RIGHTS EX-US 2024	6,575
TLXAW : PERFORMANCE SHARE APPRECIATION RIGHTS US 2025	8,298,175
TLXAS : PERFORMANCE SHARE INCENTIVE RIGHTS	440,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

View on MarketScreener

Earlier from Telix Pharmaceuticals

All Telix Pharmaceuticals news releases